(Q77410342)
Statements
Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A (English)
J N Zuckerman
C T Kirkpatrick
scientific article published on 01 March 1998
No description defined